Abbott-Solvay deal no earth-shaker

Forbes' Matthew Herper says Abbott Laboratories' (ABT) purchase of Solvay Pharmaceuticals isn't going to change the company in a big way, but the price was right. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.